Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Lundbeck scraps stroke drug

December 18, 2014 Research and Development, Sales and Marketing AIS, DIAS, Lundbeck, acute ischemic stroke, desmoteplase, stroke

Lundbeck has stopped development of its investigational stroke drug desmoteplase following disappointing results from its Phase III studies. The DIAS-3 …
News
bernard_poussot_roche

Roche adds two to its board

December 18, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernard Poussot, Richard Lift, Roche, Sanofi

Roche intends to grow at its March annual general meeting via the election of Bernard Poussot and Richard Lift who …
Appointment
research image

Big pharma spent $112 billion on R&D in 2013

December 17, 2014 Research and Development, Sales and Marketing Merck, Pfizer, R&D, Roche, data, global data, research

The top 30 pharma companies spent a combined total of $112 billion on research and development last year. Calculated to …
News
EMA image

Adaptive licensing could ‘transform industry’

December 17, 2014 Research and Development, Sales and Marketing Clinical Pharmacology & Therapeutics, EFPIA, EMA, MHRA, adaptive licesning

Drug regulators should switch to adaptive pathways as the preferred approach to bringing future new medicines to patients, according to …
News
GSK image

GSK Ebola vaccine gets EU support

December 17, 2014 Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …
News
Stevenage Bioscience Catalyst campus image

Cell Therapy Catapult to build £55 million bioscience campus

December 17, 2014 Research and Development, Sales and Marketing Cell Therapy Catapult, UK, bioscience, research, stevenage

UK firm The Cell Therapy Catapult has chosen to build a £55 million state-of-the-art cell therapy manufacturing centre in Stevenage. …
News
Janssen image

Janssen launches HIV combination pill

December 17, 2014 Research and Development, Sales and Marketing BMS, Gilead, HIV, Janssen, NHS, NICE, rezolsta, tybost

Janssen has launched its HIV therapy Rezolsta in the UK, which combines its own Prezista with Gilead’s Tybost. Prezista (darunavir) …
News
philippe_bishop_gilead

Gilead secures senior head from Genentech

December 17, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Genentech, Gilead, Philippe Bishop

Dr Philippe Bishop is joining the California-based biopharma firm Gilead from Genentech to be the company’s senior vice president of …
Appointment
Pfizer image

Pfizer buys OPKO growth hormone drug

December 16, 2014 Research and Development, Sales and Marketing Pfizer, ghd, growth, hGH-CTP, hormone, merger, opko

Pfizer will co-develop and commercialise OPKO’s growth hormone deficiency (GHD) drug hGH-CTP in a new agreement between the firms. The …
News
thomas_werner

Riemser Pharma recruits former GSK head

December 16, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, riemser pharma, thomas werner

Riemser Pharma in Germany has appointed Dr Thomas Werner to its advisory board. The former head of GlaxoSmithKline and Bristol-Myers …
Appointment
Afinitor image

Mixed bag for Novartis and Astellas in breast cancer

December 15, 2014 Research and Development, Sales and Marketing Afinitor, Astellas, Novartis, Xtandi, enzalutamide, everolimus

Preliminary results from a Phase II trial of Astellas’ Xtandi (enzalutamide) show positive benefits for the prostate cancer drug when …
News
Sam Pierce image

Celgene UK: market access is a complex business

December 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abraxane, CDF, Cancer, Celgene, PPRS, Revlimid, market access, sam pierce

Being a firm that specialises in cancer drugs, Celgene UK is no stranger to England’s notoriously rigorous approach to expensive …
Feature
veronica_g

Vermillion takes on two senior heads

December 15, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing david schreiber, vermillion, veronica jordan

US drug development firm Vermillion has appointed Veronica Jordan and David Schreiber to the company’s board of directors.  Dr Veronica …
Appointment
Janssen image

Patient access schemes ‘lack transparency’

December 12, 2014 Research and Development, Sales and Marketing Janssen, NHS, NICE, Velcade, patient access, pharma, scheme

Deals negotiated between the pharma industry and governments to allow patients access to innovative new cancer treatments risk failing because …
News
kevin_sellers_-2011

Unilife appoints comms VP from Intel

December 12, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing kevin sellers, unilife

US developer of injectable drugs Unilife has looked to Intel to appoint a marketing and communications veteran in Kevin Sellers. …
Appointment
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026